132 related articles for article (PubMed ID: 22210292)
21. A new ultra-low-dose combination oral contraceptive.
Woutersz TB
J Reprod Med; 1983 Jan; 28(1 Suppl):81-4. PubMed ID: 6403705
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the impact of vaginal and oral administration of combined hormonal contraceptives on hepatic proteins sensitive to estrogen.
Sitruk-Ware RL; Menard J; Rad M; Burggraaf J; de Kam ML; Tokay BA; Sivin I; Kluft C
Contraception; 2007 Jun; 75(6):430-7. PubMed ID: 17519148
[TBL] [Abstract][Full Text] [Related]
23. Extended regimens of the combined contraceptive vaginal ring containing etonogestrel and ethinyl estradiol: effects on lipid metabolism.
Barreiros FA; Guazzelli CA; Barbosa R; Torloni MR; Barbieri M; Araujo FF
Contraception; 2011 Aug; 84(2):155-9. PubMed ID: 21757057
[TBL] [Abstract][Full Text] [Related]
24. The effects of two monophasic oral contraceptives containing 30 mcg of ethinyl estradiol and either 2 mg of chlormadinone acetate or 0.15 mg of desogestrel on lipid, hormone and metabolic parameters.
Winkler UH; Sudik R
Contraception; 2009 Jan; 79(1):15-23. PubMed ID: 19041436
[TBL] [Abstract][Full Text] [Related]
25. A comparison of oral and transdermal short-term estrogen therapy in postmenopausal women with metabolic syndrome.
Chu MC; Cosper P; Nakhuda GS; Lobo RA
Fertil Steril; 2006 Dec; 86(6):1669-75. PubMed ID: 17074346
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of a combined oral contraceptive pill in black Zimbabwean women.
Kasule J; Mbizvo M; Makuyana D; Masona D
Cent Afr J Med; 1991 Dec; 37(12):403-9. PubMed ID: 1806254
[TBL] [Abstract][Full Text] [Related]
27. Comparison of cycle control and side effects between transdermal contraceptive patch and an oral contraceptive in women older than 35 years.
Boonyarangkul A; Taneepanichskul S
J Med Assoc Thai; 2007 Sep; 90(9):1715-9. PubMed ID: 17957909
[TBL] [Abstract][Full Text] [Related]
28. Metabolic profile of a continuous versus a cyclic low-dose combined oral contraceptive after one year of use.
Rad M; Kluft C; de Kam ML; Meijer P; Cohen AF; Grubb GS; Constantine GD; Burggraaf J
Eur J Contracept Reprod Health Care; 2011 Apr; 16(2):85-94. PubMed ID: 21417560
[TBL] [Abstract][Full Text] [Related]
29. Ovarian function with the contraceptive vaginal ring or an oral contraceptive: a randomized study.
Duijkers IJ; Klipping C; Verhoeven CH; Dieben TO
Hum Reprod; 2004 Nov; 19(11):2668-73. PubMed ID: 15333593
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of fennel and combined oral contraceptive on depot medroxyprogesterone acetate-induced amenorrhea: a randomized placebo-controlled trial.
Mohebbi-Kian E; Mohammad-Alizadeh-Charandabi S; Bekhradi R
Contraception; 2014 Oct; 90(4):440-6. PubMed ID: 24981150
[TBL] [Abstract][Full Text] [Related]
31. Serum HDL-cholesterol in women using low dose oral contraceptives.
Nessa A; Latif SA; Uddin MM; Hussain MA
Mymensingh Med J; 2007 Jul; 16(2 Suppl):S3-6. PubMed ID: 17917628
[TBL] [Abstract][Full Text] [Related]
32. Comparison of adiponectin, leptin and blood lipid levels in normal and obese postmenopausal women.
Jaleel F; Jaleel A; Rahman MA; Alam E
J Pak Med Assoc; 2006 Sep; 56(9):391-4. PubMed ID: 17091749
[TBL] [Abstract][Full Text] [Related]
33. Relationship between adipokines and lipid profile in postmenopausal women with different apolipoprotein E genotypes.
Gibas-Dorna M; Piątek J; Kupsz J; Bernatek M; Krauss H; Sowińska A; Kołodziejski P; Owoc A; Bojar I
Women Health; 2017 Sep; 57(8):891-904. PubMed ID: 27617395
[TBL] [Abstract][Full Text] [Related]
34. Protein S levels are lower in women receiving desogestrel-containing combined oral contraceptives (COCs) than in women receiving levonorgestrel-containing COCs at steady state and on cross-over.
Mackie IJ; Piegsa K; Furs SA; Johnson J; Bounds W; Machin SJ; Guillebaud J
Br J Haematol; 2001 Jun; 113(4):898-904. PubMed ID: 11442481
[TBL] [Abstract][Full Text] [Related]
35. Oral contraceptive use changes brain activity and mood in women with previous negative affect on the pill--a double-blinded, placebo-controlled randomized trial of a levonorgestrel-containing combined oral contraceptive.
Gingnell M; Engman J; Frick A; Moby L; Wikström J; Fredrikson M; Sundström-Poromaa I
Psychoneuroendocrinology; 2013 Jul; 38(7):1133-44. PubMed ID: 23219471
[TBL] [Abstract][Full Text] [Related]
36. Mental Health Symptoms in Oral Contraceptive Users During Short-Term Hormone Withdrawal.
Noachtar IA; Frokjaer VG; Pletzer B
JAMA Netw Open; 2023 Sep; 6(9):e2335957. PubMed ID: 37755829
[TBL] [Abstract][Full Text] [Related]
37. Serum lipid and adiponectin/leptin ratio changes after a Mediterranean dietary pattern in non-g-allele carriers of the genetic variant of adiponectin gene rs822393.
Primo D; Izaola O; de Luis D
Eur Rev Med Pharmacol Sci; 2021 May; 25(9):3489-3498. PubMed ID: 34002823
[TBL] [Abstract][Full Text] [Related]
38. Serum lipid and lipoprotein changes induced by preparations containing low-dose ethinylestradiol plus levonorgestrel.
Kiran G; Kiran H; Ekerbicer HC
Aust N Z J Obstet Gynaecol; 2003 Apr; 43(2):145-7. PubMed ID: 14712971
[TBL] [Abstract][Full Text] [Related]
39. Low-dose combined oral contraceptive use is associated with lower bone mineral content variation in adolescents over a 1-year period.
Biason TP; Goldberg TB; Kurokawa CS; Moretto MR; Teixeira AS; Nunes HR
BMC Endocr Disord; 2015 Apr; 15():15. PubMed ID: 25990414
[TBL] [Abstract][Full Text] [Related]
40. Is lipid profile determination necessary in women wishing to use oral contraceptives?
Machado RB; Bernardes CR; de Souza IM; Santana N; Morimoto M
Contraception; 2013 Jun; 87(6):801-5. PubMed ID: 23312931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
